Deal Details

Mirion Completes $400.0 Million Convertible Senior Notes Offering

Industrial

Mirion convertible senior notes offering

Summary

Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), recently completed an upsized private offering of $400.0 million aggregate principal amount of 0.25% Convertible Senior Notes due 2030 (the “Notes”) pursuant to Rule 144A (the “Offering”), which includes the exercise in full by the initial purchasers of their option to purchase an additional $50.0 million of Notes. The size of the Offering was increased from the previously announced $300.0 million aggregate principal amount of Notes. Mirion intends to use the net proceeds from the Offering to pay the cost of capped call transactions, repay outstanding term loans, repurchase $31.0 million of common stock and for general corporate purposes and working capital.

Baird served as a co-manager on this Offering.

About

Mirion is a global provider of radiation detection, measurement, analysis and monitoring products and services to the medical, nuclear and defense end markets. Mirion provides products and services through two operating and reportable segments; Medical and Nuclear & Safety. The Medical segment provides radiation oncology quality assurance, dosimetry solutions, radiation therapy quality assurance solutions and radionuclide therapy products. The Nuclear & Safety segment provides robust, field ready personal radiation detection and identification equipment for defense applications and radiation detection and analysis tools for power plants, labs, and research applications. Mirion is headquartered in Atlanta, Georgia.